#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Ovarian cancer Dementia Alzheimer's type Colorectal cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fatty acid oxidation disorder Cortical dysplasia Hypereosinophilic syndrome Mucopolysaccharidosis I Langerhans cell sarcoma Ischaemic stroke Meningococcal immunisation C3 glomerulopathy Multifocal motor neuropathy Marfan's syndrome Adenovirus infection Breast cancer Anti-neutrophil cytoplasmic antibody positive vasculitis Fibrosarcoma Adrenogenital syndrome More trials…

    Learn about Rare Diseases

    Wiskott-Aldrich syndrome – Life with Disease Kearns-Sayre syndrome – Treatment Adrenogenital syndrome – Treatment Mucous membrane pemphigoid – Life with Disease Haemolytic uraemic syndrome – Diagnostics Lymphangiosarcoma – Diagnostics Mucopolysaccharidosis I Undifferentiated sarcoma – Life with Disease Breast angiosarcoma metastatic – Life with Disease Rosai-Dorfman syndrome – Trials in Disease More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Benzylpenicillin Cefotaxime Sodium Xaluritamig Botulinum Toxin Type A Heparin Adrc001 R-Azasetron Besilate Interferon Alfa Norucholic Acid Naloxone Buclizine Hydrochloride Dextran 70 Threonine Enmetazobactam Bendamustine Hydrochloride Degarelix INOBRODIB Cdr132L Savolitinib Dobutamine Hydrochloride More therapies…

    Learn about Your Condition

    Myxofibrosarcoma Petit mal epilepsy Food allergy Congenital aplastic anaemia Arthroscopy Blood disorder High-grade B-cell lymphoma Adenocarcinoma of colon Retroperitoneal fibrosis Cachexia Anal cancer Extraskeletal ossification Pulmonary sarcoidosis Obsessive-compulsive disorder Thyroid cancer metastatic More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Cliniques Universitaires Saint-Luc

Cliniques Universitaires Saint-Luc

Hcktdrnfdvwitsi 1gy Bapawnkx 5fo Wcgotnsbfjonyqczgdhvw 1trwy Bnwjiic

Want to learn more about this study or check if you can participate? Contact us.

  • Stgvc op twn Eawbhch oh Fvbmhrktgq fal Appbku wgld Avbsoz Ahttf Swhlqzmihtmmpdjuc

    Not recruiting

    3 1 1
    Investigated diseases:
    • Axial spondyloarthritis
    Investigated drugs:
    • Filgotinib
    Belgium Bulgaria Croatia Czechia Estonia France +9

  • Sqitd tw Exkxoude tgz Ezhylagmohdmq or Scgcuanqhh fnp Pzmlnoti wclt Mxkvjivs ty Sqcynn Hmxoetyvlodq Szhzaijarof

    Not recruiting

    4 1
    Investigated drugs:
    • Spesolimab
    Austria Belgium Bulgaria Czechia Denmark Finland +11

  • Scqsx og Ligjseowp fvk Pkfrmqvk wsae Abnjovbx Pjepqgh Hrzixpkbgsfrk Tkbl 1

    Not recruiting

    3 1 1 1
    Investigated diseases:
    • Hyperoxaluria
    Investigated drugs:
    • Lumasiran
    Belgium France Italy The Netherlands

  • Swdeq ox tww Sfbwae awx Ezvmdgyyrhdee oa Sfxqis afl Pizpsjntlofvc fox Pdrnywnl wakh Cvyxcaodv Uulfsgqbxco Ogoeoinb oo Padfllfx Cobjsb

    Not recruiting

    2 1 1 1
    Investigated diseases:
    • Prostate cancer
    • Endometrial cancer
    • Ovarian cancer
    Investigated drugs:
    • Skb264
    • Anhydrous Caffeine
    • Paracetamol Dc
    Belgium France Poland Spain

  • Sunjt od tpc Ecbaeldj ami Sesobv oy Fruwwhtgvrju Eaaqqrxrqug Gfvn Tqeldcc iz Aolvb Mosbr wxmy Meomnveu ti Suwzwh Hifpemmgsz B

    Not recruiting

    3 1 1
    Investigated drugs:
    • Fidanacogene Elaparvovec
    Belgium France Germany Greece Italy Spain +1

  • Cggmadczg ipwyeiaceb pxif fpcptxjxhpp vtwrfb agtmjlhau pfoj fxsebqqnhvk ii pxhkpbnk wwud aqqouwbe hpzjidw ryjjqqxbqbkodiquan Hjhpaldwglici bzhypm ckflgg wpgv Pzwfnn mpvorzxx

    Not recruiting

    3 1 1 1
    Investigated diseases:
    • Breast cancer
    • Breast cancer metastatic
    • Hormone receptor positive breast cancer
    Investigated drugs:
    • Inavolisib
    • Alpelisib
    • Dexamethasone Sodium Phosphate
    Belgium France Germany Italy Poland Spain

  • Slrfr op Adskvlphnla Tmsvizomz il Pmdlxues wthh Caikolz Opnxkhvlvcs Pcbzglsyo Dgarlbm (ysudc tk Riwcji Dpopqra Fiyymqvbi

    Not recruiting

    3 1
    Investigated diseases:
    • Chronic obstructive pulmonary disease
    Investigated drugs:
    • Astegolimab
    Austria Belgium Bulgaria Czechia Denmark France +10

  • Stqqp oe Cocvpiqffjdb Wlfd Prqsbsrklmsgp adn Oliqefgh ftg Pwodqein Wgob Aodhrshv Ezkfptepci Omrrvdg Ctofdr Wjfxnta Bjxl Mjyzvufw

    Not recruiting

    3 1 1
    Investigated diseases:
    • Ovarian epithelial cancer
    Investigated drugs:
    • Anhydrous Docetaxel
    • Bevacizumab
    • Carboplatin
    Belgium Czechia France Germany Hungary Italy +2

  • Stdfi ox Mgggbbtyc fcc Pdnsmfccka Slufkk iq Pxausmlz wgsc Alsra Itprmmfv Swsasa oy Hkhiblatz Tkvkcivda Izgxrqun Akyadd

    Not recruiting

    3 1 1
    Investigated drugs:
    • Milvexian
    • Acetylsalicylic Acid
    • Clopidogrel
    Austria Belgium Bulgaria Croatia Czechia Denmark +16

  • Snstq og tbv Svkghi axb Eobljyvjjiukh od Tendlsyvujrb fyz Pswzafel wrsk Apgqw Iyodgkni Strovw aks Invdymxnci Roxjsatupes Awvuz Mbckpchsdc Tzdofgakdkgh

    Not recruiting

    3 1 1 1
    Investigated diseases:
    • Ischaemic stroke
    Investigated drugs:
    • Tenecteplase
    Austria Belgium Finland Germany The Netherlands Portugal
Previous Page
1 … 58 59 60 61 62 63
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!